Results 261 to 270 of about 646,520 (340)
Celiac-associated pancreatic disease. [PDF]
Freeman HJ.
europepmc +1 more source
Discovery of a Potent and Selective TEAD Degrader with Durable Degradation Activity
KG‐FP‐003, a highly potent TEAD‐YAP PROTAC derived from the patented inhibitor is developed. It selectively degrades endogenous TEAD proteins in HiBiT systems without IMiD‐related off‐target effects. Screening across 867 cancer cell lines revealed broad and superior anti‐tumor activity, highlighting its therapeutic potential through targeted TEAD ...
Linhui Cao +25 more
wiley +1 more source
This study investigates the deacetylation of ACLY at K978 acts as a novel risk in colorectal cancer chemoresistance. The deacetylation of K978 induces ACLY relocation to the nucleus and promotes its binding to RBM15, a m6A methylation modification “writer”.
Jun Wen +8 more
wiley +1 more source
A closed‐loop bioelectronic artificial pancreas patch is presented for glucose monitoring and regulation. Utilizing transiently dissolvable microneedle arrays integrated with microtube arrays, the patch efficiently delivers insulin into interstitial fluid, eliminating the need for external long needles. In diabetic pigs, it demonstrates excellent blood
Yiqun Liu +9 more
wiley +1 more source
Pancreatic Exocrine Function in Patients with Chronic Liver Disease.
Terufumi Sakai
openalex +2 more sources
ENTPD5‐mediated conversion of extracellular adenosine triphosphate to ADP of hepatocytes is critical for maintaining hepatic glucose/lipid metabolism and promoting brown adipose tissue thermogenesis via the inhibition of adrenomedullin expression and secretion.
Rufeng Ma +9 more
wiley +1 more source
Insights into the genetic risk factors for the development of pancreatic disease. [PDF]
Zator Z, Whitcomb DC.
europepmc +1 more source

